scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Linlin Wang | |
Helen Ka Wai Law | |||
P2860 | cites work | Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction | Q24303900 |
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci | Q24306903 | ||
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis | Q24606320 | ||
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus | Q24629130 | ||
Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death | Q24652950 | ||
Autophagy in the Pathogenesis of Disease | Q27860558 | ||
Autophagy fights disease through cellular self-digestion | Q27860902 | ||
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging | Q28081442 | ||
Autophagy is activated in systemic lupus erythematosus and required for plasmablast development | Q28656075 | ||
Low dose rapamycin exacerbates autoimmune experimental uveitis | Q28730115 | ||
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians | Q28943338 | ||
Autophagy: process and function | Q29547296 | ||
Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
Development by self-digestion: molecular mechanisms and biological functions of autophagy | Q29547880 | ||
Autophagy-dependent viral recognition by plasmacytoid dendritic cells | Q29614177 | ||
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production | Q29614472 | ||
The role of autophagy in neurodegenerative disease | Q29614834 | ||
Autophagy in health and disease: a double-edged sword | Q29618103 | ||
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry | Q33364289 | ||
Aberrant Epstein-Barr viral infection in systemic lupus erythematosus | Q33655378 | ||
Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. | Q33719767 | ||
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins | Q33841180 | ||
The role of PI3P phosphatases in the regulation of autophagy | Q33914205 | ||
Microautophagy in mammalian cells: revisiting a 40-year-old conundrum | Q34190348 | ||
Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy. | Q34270321 | ||
HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus. | Q34625909 | ||
Exposure to maternal smoking and incident SLE in a prospective cohort study | Q35088861 | ||
Chaperone-mediated autophagy | Q35107699 | ||
Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment. | Q35439721 | ||
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1) | Q35583137 | ||
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial | Q35658566 | ||
The expression of EBV-encoded LMP1 in young patients with lupus nephritis. | Q35792180 | ||
Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes | Q35910776 | ||
The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. | Q51547435 | ||
DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features. | Q51752532 | ||
The pathogenesis of lupus nephritis. | Q51868414 | ||
Plasma cells require autophagy for sustainable immunoglobulin production. | Q53122740 | ||
Systemic lupus erythematosus. | Q53202066 | ||
Epstein-Barr virus and systemic lupus erythematosus | Q58908905 | ||
Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease | Q60250015 | ||
Systemic lupus erythematosus and the neutrophil | Q84816491 | ||
The Atg5 Atg12 conjugate associates with innate antiviral immune responses | Q35956883 | ||
Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. | Q36111664 | ||
Macroautophagy is deregulated in murine and human lupus T lymphocytes | Q36194783 | ||
Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases | Q36235457 | ||
Ultraviolet light and cutaneous lupus | Q36676995 | ||
ATG5 regulates plasma cell differentiation | Q36769690 | ||
Innate and adaptive immunity through autophagy | Q36896712 | ||
Unveiling the roles of autophagy in innate and adaptive immunity | Q36927499 | ||
Pivotal role for the mTOR pathway in the formation of neutrophil extracellular traps via regulation of autophagy | Q37093598 | ||
Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis | Q37129534 | ||
The expression of renal Epstein-Barr virus markers in patients with lupus nephritis | Q37710075 | ||
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1 | Q37728822 | ||
Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus | Q37777065 | ||
Hydroxychloroquine: from malaria to autoimmunity | Q37827403 | ||
Autophagy and cytokines | Q37926024 | ||
Autophagy and the immune system | Q37997062 | ||
Lupus nephritis and end-stage kidney disease | Q38078211 | ||
Emerging view of autophagy in systemic lupus erythematosus. | Q38189443 | ||
Autophagy in antimicrobial immunity | Q38207186 | ||
Treatment of severe lupus nephritis: the new horizon. | Q38271125 | ||
Resetting the autoreactive immune system with a therapeutic peptide in lupus | Q38388415 | ||
Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy | Q38397636 | ||
Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production | Q38963312 | ||
Glucocorticoids downregulate Fyn and inhibit IP3-mediated calcium signaling to promote autophagy in T lymphocytes | Q39660061 | ||
Modulation of local PtdIns3P levels by the PI phosphatase MTMR3 regulates constitutive autophagy | Q39754404 | ||
Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice | Q39812158 | ||
The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy | Q40044863 | ||
Apolipoprotein L1-associated nephropathy and the future of renal diagnostics | Q42943112 | ||
Raised antibody titres to E.B. virus in systemic lupus erythematosus | Q45059909 | ||
Nephrotoxicity of rapamycin: an emerging problem in clinical medicine | Q45211831 | ||
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure | Q45737398 | ||
Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers | Q45747821 | ||
Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. | Q46619969 | ||
Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population | Q46869773 | ||
Sun-induced life-threatening lupus nephritis | Q46982885 | ||
Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience. | Q47361768 | ||
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. | Q47565748 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autophagy | Q288322 |
lupus nephritis | Q1621830 | ||
autoantigen | Q4072475 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 25154-67 | |
P577 | publication date | 2015-10-22 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | The Role of Autophagy in Lupus Nephritis | |
P478 | volume | 16 |
Q93047803 | Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice |
Q61814941 | Autophagy in Chronic Kidney Diseases |
Q93272821 | Autophagy-mediated regulation of neutrophils and clinical applications |
Q38926368 | Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis |
Q39226501 | Emerging Roles of IL-33/ST2 Axis in Renal Diseases. |
Q90482011 | Exacerbating lupus nephritis following BPA exposure is associated with abnormal autophagy in MRL/lpr mice |
Q91887909 | High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus |
Q39031764 | Hydroxychloroquine in systemic lupus erythematosus (SLE). |
Q89241556 | Increased Macroautophagy in Interferon-Gamma-Producing T Cells from Patients with Newly Diagnosed Systemic Lupus Erythematosus |
Q95320598 | Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy |
Q38634529 | Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions |
Q55455268 | More Than Skin Deep: Autophagy Is Vital for Skin Barrier Function. |
Q92222878 | Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus |
Q39198894 | Regulatory effects of autophagy on spermatogenesis |
Q42282538 | Role of autophagy in cell-penetrating peptide transfection model. |
Q92956352 | The Role of NETosis in Systemic Lupus Erythematosus |
Q39100146 | UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis? |
Q60910374 | Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy |
Search more.